LGLoïc Guimbaud

Loïc Guimbaud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Loïc Guimbaud has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    JoVE Video Dataset

    by Hélène Martin, Charlène Martin, Loïc Guimbaud, Delphine Duchanois, Paul Guerby, Cécile E. Malnou

    The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.

  • Open Access

    Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface

    by Hélène Martin, Charlène Martin, Loïc Guimbaud, Delphine Duchanois, Paul Guerby, Cécile E. Malnou

    The placenta plays a critical role during pregnancy, enabling maternal-fetal exchange while serving as a barrier against pathogens. However, some viruses, including human cytomegalovirus (HCMV) or Zika virus (ZIKV), can cross this barrier and cause congenital infections, leading to severe fetal outcomes such as growth restriction, impairment of brain development, or fetal demise. Understanding how viruses infect and disseminate through the placenta is therefore essential. To investigate viral vertical transmission in a physiologically relevant context, an ex vivo model using human placental explants cultured at the air-liquid interface on gelatin sponges can be used and offers several advantages. Unlike conventional in vitro systems limited to single-cell types, this model preserves the multicellular structure and function of the placental tissue for up to three weeks. This model is compatible with a wide range of upstream experimental applications (histological analyses, RT-qPCR, TUNEL assay, quantification of secreted factors, etc.), making it a robust and accessible platform to study viral replication, immune responses, and placental barrier function under near-physiological conditions.